These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15969119)
1. [Particulate recombinant hepatitis E virus capsid protein and its antigenicity and immunogenicity]. He ZQ; Zhang J; Li SW; Lin J; Liu RS; Chen YX; Wang YB; Xia NS Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):262-8. PubMed ID: 15969119 [TBL] [Abstract][Full Text] [Related]
2. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology]. Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579 [TBL] [Abstract][Full Text] [Related]
3. [The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli]. Ge S; Zhang J; Huang G; Pang S; Zhou K; Xia N Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):35-42. PubMed ID: 16276869 [TBL] [Abstract][Full Text] [Related]
4. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle]. Dong C; Meng JH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795 [TBL] [Abstract][Full Text] [Related]
5. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Zhang J; Gu Y; Ge SX; Li SW; He ZQ; Huang GY; Zhuang H; Ng MH; Xia NS Vaccine; 2005 Apr; 23(22):2881-92. PubMed ID: 15780737 [TBL] [Abstract][Full Text] [Related]
6. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris]. Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572 [TBL] [Abstract][Full Text] [Related]
7. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Li SW; Zhang J; Li YM; Ou SH; Huang GY; He ZQ; Ge SX; Xian YL; Pang SQ; Ng MH; Xia NS Vaccine; 2005 Apr; 23(22):2893-901. PubMed ID: 15780738 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540 [TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of recombinant HEV ORF2 protein expressed in pichia pastoris]. Tong Y; Zhan M; Lu J; Bai Y; Bi S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):23-6. PubMed ID: 11986739 [TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio]. Dong C; Dai X; Meng JH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906 [TBL] [Abstract][Full Text] [Related]
12. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Dong C; Dai X; Meng JH Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900 [TBL] [Abstract][Full Text] [Related]
13. Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein. Guo H; Zhou EM; Sun ZF; Meng XJ Vaccine; 2007 Apr; 25(15):2892-9. PubMed ID: 17074425 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates. Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777 [TBL] [Abstract][Full Text] [Related]
15. [Interface domain of hepatitis E virus capsid protein homodimer]. Li SW; He ZQ; Wang YB; Chen YX; Liu RS; Lin J; Gu Y; Zhang J; Xia NS Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):90-8. PubMed ID: 16108497 [TBL] [Abstract][Full Text] [Related]
16. [Vaccination of rhesus monkeys with recombinant antigen fragments and protection from hepatitis E virus infection]. Ma YB; Xie TH; Zhang GM; Li CH; Dai XJ; Dai CB; Sun MS; Lu J; Bi SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):592-5. PubMed ID: 12905686 [TBL] [Abstract][Full Text] [Related]
17. A new artificial antigen of the hepatitis E virus. Ulanova TI; Obriadina AP; Talekar G; Burkov AN; Fields HA; Khudyakov YE J Immunoassay Immunochem; 2009; 30(1):18-39. PubMed ID: 19117200 [TBL] [Abstract][Full Text] [Related]
18. Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity. Wu T; Wu XL; Ou SH; Lin CX; Cheng T; Li SW; Ng MH; Zhang J; Xia NS Mol Immunol; 2007 May; 44(12):3261-6. PubMed ID: 17408743 [TBL] [Abstract][Full Text] [Related]
19. [Construction of a recombinant human adenovirus expressing the ORF2 antigen of HEV and immunization of mice by mucosal system]. Dong X; Hu JY; Xie TH; Sun MS; Dai CB; Ma YB Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):324-8. PubMed ID: 12905749 [TBL] [Abstract][Full Text] [Related]
20. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV]. Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]